Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Bilateral gangrene of fingers in a patient on empagliflozin: First case report.

< BACK TO ARCHIVE


2019 Feb 15


World J Diabetes


http://www.ncbi.nlm.nih.gov/pubmed/30788049?dopt=Abstract


10


2

Bilateral gangrene of fingers in a patient on empagliflozin: First case report.

Authors

Bilateral gangrene of fingers in a patient on empagliflozin: First case report.
Ramachandra Pai R P, Kangath R V
World J Diabetes. 2019 Feb 15; 10(2):133-136.
PMID: 30788049.

Abstract

Sodium glucose cotransporter 2 (SGLT2) inhibitors use has been associated with toe amputations and non-healing ulcers and gangrene mostly of lower extremities. There are no case reports about association of Empagliflozin with finger ulcers or gangrene. This is the first case report of Empagliflozin (Jardiance) an SGLT2 inhibitor causing gangrene of fingers and second case in literature about any SGLT2 inhibitor causing gangrene of upper extremity.
Read This Paper